| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |